Disability, Developmental Clinical Trial
Official title:
Safe Drug Use in People With Intellectual and/or Developmental Disabilities - it Applies to Life
Verified date | November 2023 |
Source | Vestvagoy Municipality |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The innovation idea is to develop valuable new knowledge about safe drug use in people with intellectual and/or developmental disabilities (IDDs). The main goal is to design a framework (routines and processes) that ensures safe drug use and provides qualitatively better services for people with IDDs. Secondary goals are that employees will experience better security when working with medicines, and interact better with people with IDD and relatives by implementing digital support functions. The innovation idea is specifically to develop/improve the following: 1) Medication management: Coordinating routines, procedures and work processes regarding all aspects of drug use, medication handling, and communication between care units for people with IDDs. 2) Medication therapy: Chart review of prescribed medication and gather knowledge about challenges related to drug use in this group. Based on this, we will develop new methods for drug reconciliation and medication reviews to optimize drug use. 3) New framework for safe drug use in the community-based services for people with IDDs.
Status | Active, not recruiting |
Enrollment | 110 |
Est. completion date | July 31, 2027 |
Est. primary completion date | July 31, 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Year to 99 Years |
Eligibility | Inclusion Criteria: - Users of the municipality's Service for people with disabilities Exclusion Criteria: - |
Country | Name | City | State |
---|---|---|---|
Norway | Vestvågøy Municipality | Leknes |
Lead Sponsor | Collaborator |
---|---|
Vestvagoy Municipality | University of Oslo, University of Tromso |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To understand what is safe drug therapy and drug handling in people with intellectual and/or developmental disabilities | Map which drugs each patient uses and carry out medication reconciliation (nurse and pharmacist) and medication review (nurse, pharmacist and general general practitioner).
Interviews of employees, GPs and pharmacy staff. |
12 months | |
Primary | Formulation of multidisciplinary frameworks for optimizing drug handling and drug therapy. | Design thinking and co-creation of multidisciplinary frameworks | 18 months | |
Primary | Explore usefulness of multidisciplinary frameworks | Transcripts of qualitative feedback. Follow-up survey of employees, GPs, pharmacy staff, and people with intellectual and/or developmental disabilities. Health economic evaluation. | 18 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05350904 -
Hybrid Telehealth in Pediatric Physical Therapy
|
N/A | |
Not yet recruiting |
NCT03508583 -
Turkish Version of The Measure of Processes of Care (MPOC)
|
||
Recruiting |
NCT06156124 -
The Role of Family and Individual Factors in Going Through Adolescence - Perspective of a Healthy Child.
|
||
Completed |
NCT03830476 -
Navigator ACT Group Intervention for Parents of Children With Disabilities
|
N/A | |
Recruiting |
NCT04686565 -
Covid-19 Pandemic and Cerebral Palsy
|
||
Recruiting |
NCT04481334 -
Study: Effects of a Collaborative Occupational Therapy Interactive Vaulting
|
N/A | |
Completed |
NCT03653754 -
Growth and Body Composition in Children
|